ANIK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Anika Therapeutics Inc

Watchlist Manager

Watchlist

Price: 14.95 USD 1.91% Market Closed

Market Cap: $199m

	Anika Therapeutics Inc NASDAQ:ANIK	US
	Galapagos NV OTC:GLPGF	BE
I	IDT Corp XMUN:IDC2	US
A	American States Water Co XBER:FDK	US
	EQT Corp NYSE:EQT	US
J	JAFCO Group Co Ltd XHAM:JAF	JP
M	MacroAsia Corp XPHS:MAC	PH
C	Carlsberg A/S SWB:CBGA	DK
X	Xinhua Winshare Publishing and Media Co Ltd F:SXV	CN
	Sg Company SpA MIL:SGC	IT

Profitability Summary

Anika Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

61% > 59%

Negative Operating Margin

-9%

Negative 3Y Average Operating Margin

-7%

Operating Margin is Increasing

-14% > -9%

Negative Net Margin

-10%

Negative 3Y Average Net Margin

-36%

Net Margin is Increasing

-14% > -10%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-2%

Free Cash Flow Margin is Increasing

-10% > 1%

Negative ROE

-8%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7%

Declining ROIC

-7% > -9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.